These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25063434)

  • 1. A critical evaluation of inflammatory markers in Huntington's Disease plasma.
    Silajdžić E; Rezeli M; Végvári Á; Lahiri N; Andre R; Magnusson-Lind A; Nambron R; Kalliolia E; Marko-Varga G; Warner TT; Laurell T; Tabrizi SJ; Björkqvist M
    J Huntingtons Dis; 2013; 2(1):125-34. PubMed ID: 25063434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
    Chang KH; Wu YR; Chen YC; Chen CM
    Brain Behav Immun; 2015 Feb; 44():121-7. PubMed ID: 25266150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects.
    Corey-Bloom J; Fischer RS; Kim A; Snell C; Parkin GM; Granger DA; Granger SW; Thomas EA
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
    Leoni V; Mariotti C; Tabrizi SJ; Valenza M; Wild EJ; Henley SM; Hobbs NZ; Mandelli ML; Grisoli M; Björkhem I; Cattaneo E; Di Donato S
    Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.
    Sánchez-López F; Tasset I; Agüera E; Feijóo M; Fernández-Bolaños R; Sánchez FM; Ruiz MC; Cruz AH; Gascón F; Túnez I
    Neurol Res; 2012 Sep; 34(7):721-4. PubMed ID: 22889672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.
    Politis M; Lahiri N; Niccolini F; Su P; Wu K; Giannetti P; Scahill RI; Turkheimer FE; Tabrizi SJ; Piccini P
    Neurobiol Dis; 2015 Nov; 83():115-21. PubMed ID: 26297319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.
    Dalrymple A; Wild EJ; Joubert R; Sathasivam K; Björkqvist M; Petersén A; Jackson GS; Isaacs JD; Kristiansen M; Bates GP; Leavitt BR; Keir G; Ward M; Tabrizi SJ
    J Proteome Res; 2007 Jul; 6(7):2833-40. PubMed ID: 17552550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disturbances in plasma as biomarkers for Huntington's disease.
    Cheng ML; Chang KH; Wu YR; Chen CM
    J Nutr Biochem; 2016 May; 31():38-44. PubMed ID: 27133422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease.
    Du G; Dong W; Yang Q; Yu X; Ma J; Gu W; Huang Y
    Front Immunol; 2020; 11():603594. PubMed ID: 33679692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's disease.
    Pido-Lopez J; Andre R; Benjamin AC; Ali N; Farag S; Tabrizi SJ; Bates GP
    Sci Rep; 2018 Jul; 8(1):11447. PubMed ID: 30061661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.
    Niemelä V; Burman J; Blennow K; Zetterberg H; Larsson A; Sundblom J
    PLoS One; 2018; 13(2):e0193492. PubMed ID: 29474427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.
    Dobson L; Träger U; Farmer R; Hayardeny L; Loupe P; Hayden MR; Tabrizi SJ
    J Neurochem; 2016 Jun; 137(5):782-94. PubMed ID: 26823290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in Huntington's disease: A few new twists on an old tale.
    Valadão PAC; Santos KBS; Ferreira E Vieira TH; Macedo E Cordeiro T; Teixeira AL; Guatimosim C; de Miranda AS
    J Neuroimmunol; 2020 Nov; 348():577380. PubMed ID: 32896821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.
    Klepac N; Relja M; Klepac R; Hećimović S; Babić T; Trkulja V
    J Neurol; 2007 Dec; 254(12):1676-83. PubMed ID: 17990062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study.
    McGarry A; Gaughan J; Hackmyer C; Lovett J; Khadeer M; Shaikh H; Pradhan B; Ferraro TN; Wainer IW; Moaddel R
    Sci Rep; 2020 Nov; 10(1):20490. PubMed ID: 33235276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
    Barschke P; Abu-Rumeileh S; Al Shweiki MHDR; Barba L; Paolini Paoletti F; Oeckl P; Steinacker P; Halbgebauer S; Gaetani L; Lewerenz J; Ludolph AC; Landwehrmeyer GB; Parnetti L; Otto M
    J Neurol; 2022 Sep; 269(9):5136-5143. PubMed ID: 35737109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
    Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
    Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the immune system in Huntington's disease.
    Ellrichmann G; Reick C; Saft C; Linker RA
    Clin Dev Immunol; 2013; 2013():541259. PubMed ID: 23956761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.